{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":22,"n_cols":5,"rows_kept":22,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[15,2,15,3],[16,2,16,3],[21,2,21,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910716970303321"]
[null,null,"Titolo",null,"Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ."]
[null,null,"Pubbl/distr/stampa",null,"Washington : , : U.S. G.P.O., , 1980-"]
[null,null,"Descrizione fisica",null,"1 online resource"]
[null,null,"Soggetti",null,"Pharmaceutical policy - United States"]
[{"$nulls":4},"Drugs - United States - Testing"]
[{"$nulls":4},"Pharmaceutical industry - United States"]
[{"$nulls":4},"Drug Industry"]
[{"$nulls":4},"Pharmaceutical Preparations - standards"]
[{"$nulls":4},"Research - standards"]
[{"$nulls":4},"Drugs - Testing"]
[{"$nulls":4},"Pharmaceutical industry"]
[{"$nulls":4},"Pharmaceutical policy"]
[{"$nulls":4},"Legislative hearings."]
[{"$nulls":4},"United States"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Access ID (govinfo): CHRG-96hhrg70300Ov2."]
[{"$nulls":4},"\"Serial no. 96-170.\""]
[{"$nulls":4},"\"Serial no. 96-216.\""]
[null,null,"Nota di contenuto",null,"v. 1. New drug approval process -- v. 2. Orphan drugs."]